These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
264 related items for PubMed ID: 17257273
1. Prognostic role of B-type natriuretic peptide in patients with diabetes and acute decompensated heart failure. Aspromonte N, Feola M, Milli M, Scardovi AB, Coletta C, Carbonieri E, Giovinazzo P, Di Giacomo T, Barro S, Rosso GL, Ceci V, Milani L, Valle R. Diabet Med; 2007 Feb; 24(2):124-30. PubMed ID: 17257273 [Abstract] [Full Text] [Related]
2. B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function. Valle R, Aspromonte N, Feola M, Milli M, Canali C, Giovinazzo P, Carbonieri E, Ceci V, Cerisano S, Barro S, Milani L. J Card Fail; 2005 Sep; 11(7):498-503. PubMed ID: 16198244 [Abstract] [Full Text] [Related]
3. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern. Feola M, Aspromonte N, Milani L, Bobbio M, Bardellotto S, Barro S, Giovinazzo P, Noventa F, Valle R. J Card Fail; 2008 Jun; 14(5):420-5. PubMed ID: 18514935 [Abstract] [Full Text] [Related]
4. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities. Ang DS, Kong CF, Kao MP, Struthers AD. Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403 [Abstract] [Full Text] [Related]
5. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure. Nishii M, Inomata T, Takehana H, Naruke T, Yanagisawa T, Moriguchi M, Takeda S, Izumi T. J Am Coll Cardiol; 2008 Jun 17; 51(24):2329-35. PubMed ID: 18549918 [Abstract] [Full Text] [Related]
6. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction. Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E. Am J Cardiol; 2008 Sep 15; 102(6):733-7. PubMed ID: 18773998 [Abstract] [Full Text] [Related]
7. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. Maisel A, Hollander JE, Guss D, McCullough P, Nowak R, Green G, Saltzberg M, Ellison SR, Bhalla MA, Bhalla V, Clopton P, Jesse R, Rapid Emergency Department Heart Failure Outpatient Trial investigators. J Am Coll Cardiol; 2004 Sep 15; 44(6):1328-33. PubMed ID: 15364340 [Abstract] [Full Text] [Related]
8. Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus. Bhalla MA, Chiang A, Epshteyn VA, Kazanegra R, Bhalla V, Clopton P, Krishnaswamy P, Morrison LK, Chiu A, Gardetto N, Mudaliar S, Edelman SV, Henry RR, Maisel AS. J Am Coll Cardiol; 2004 Sep 01; 44(5):1047-52. PubMed ID: 15337217 [Abstract] [Full Text] [Related]
9. Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department (from the PRIDE Study). O'Donoghue M, Kenney P, Oestreicher E, Anwaruddin S, Baggish AL, Krauser DG, Chen A, Tung R, Cameron R, Januzzi JL. Am J Cardiol; 2007 Nov 01; 100(9):1336-40. PubMed ID: 17950786 [Abstract] [Full Text] [Related]
10. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease. Bruch C, Fischer C, Sindermann J, Stypmann J, Breithardt G, Gradaus R. Am J Cardiol; 2008 Aug 15; 102(4):469-74. PubMed ID: 18678308 [Abstract] [Full Text] [Related]
11. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Parissis JT, Nikolaou M, Birmpa D, Farmakis D, Paraskevaidis I, Bistola V, Katsoulas T, Filippatos G, Kremastinos DT. Am J Cardiol; 2009 Jan 01; 103(1):73-5. PubMed ID: 19101233 [Abstract] [Full Text] [Related]
12. B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study. Schnabel R, Lubos E, Rupprecht HJ, Espinola-Klein C, Bickel C, Lackner KJ, Cambien F, Tiret L, Münzel T, Blankenberg S. J Am Coll Cardiol; 2006 Feb 07; 47(3):552-8. PubMed ID: 16458135 [Abstract] [Full Text] [Related]
14. Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Kucher N, Printzen G, Goldhaber SZ. Circulation; 2003 May 27; 107(20):2545-7. PubMed ID: 12742987 [Abstract] [Full Text] [Related]
18. Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF. Takami Y, Horio T, Iwashima Y, Takiuchi S, Kamide K, Yoshihara F, Nakamura S, Nakahama H, Inenaga T, Kangawa K, Kawano Y. Am J Kidney Dis; 2004 Sep 27; 44(3):420-8. PubMed ID: 15332214 [Abstract] [Full Text] [Related]
19. Incremental prognostic values of serum tenascin-C levels with blood B-type natriuretic peptide testing at discharge in patients with dilated cardiomyopathy and decompensated heart failure. Fujimoto N, Onishi K, Sato A, Terasaki F, Tsukada B, Nozato T, Yamada T, Imanaka-Yoshida K, Yoshida T, Ito M, Hiroe M. J Card Fail; 2009 Dec 27; 15(10):898-905. PubMed ID: 19944367 [Abstract] [Full Text] [Related]
20. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure. Valle R, Aspromonte N, Giovinazzo P, Carbonieri E, Chiatto M, di Tano G, Feola M, Milli M, Fontebasso A, Barro S, Bardellotto S, Milani L. J Card Fail; 2008 Apr 27; 14(3):219-24. PubMed ID: 18381185 [Abstract] [Full Text] [Related] Page: [Next] [New Search]